pharmaceutical background. medical safety background with floating capsules and copy space. pharmaceutical quality control and secure drug production. minimalistic design trust in modern medicine.

Con­ver­si­on for inter-mar­ket tran­sac­tions

15 August 2022

On Thursday, 18.08.2022, a changeover will take place in the securPharm system: In the special case of intermarket transactions (IMT for short), a so-called temporarily consistent client ID will be transmitted from the changeover onwards. In this case, temporary means that the client ID will be replaced by a new...
Learn More ...

Euro­pean Com­mis­si­on Q&A Ver­si­on 20

11 Juli 2022

The European Commission has published a new version of the Questions & Answers (Q&A) document on "Safety features for medicinal products for human use (V.20)". New is question 5.14: Is it allowed to verify the authenticity of the UI when the product is not in physical possession? The document can...
Learn More ...

Phar­maceu­ti­cal dona­ti­ons to Ukrai­ne

16 Mai 2022

The Federal Ministry of Health, Department 1 (Medicinal Products, Medical Devices, Biotechnology) informed in a letter dated May 11, 2022 that it is justifiable to donate medicinal products to Ukraine without deactivating the unique identifier (by the pharmaceutical manufacturers). The procedure has been coordinated with the state authorities. The BMG...
Learn More ...

ABDA publishes updated FAQs

27 April 2022

ABDA has updated its securPharm FAQs and made them available on its website. On 48 pages, pharmacy teams can now find the right answers to questions relating to daily use of the securPharm system, as well as questions on how to deal with packs from the UK. In addition, the...
Learn More ...

Sta­tus report 2022 online

08 April 2022

The 2022 status report is online. It reports on securPharm's activities and the operation of the securPharm system in 2021. The status report is available in German and in English.
Learn More ...